1. Home
  2. EDIT vs FRST Comparison

EDIT vs FRST Comparison

Compare EDIT & FRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDIT
  • FRST
  • Stock Information
  • Founded
  • EDIT 2013
  • FRST 2004
  • Country
  • EDIT United States
  • FRST United States
  • Employees
  • EDIT N/A
  • FRST N/A
  • Industry
  • EDIT Biotechnology: Biological Products (No Diagnostic Substances)
  • FRST Major Banks
  • Sector
  • EDIT Health Care
  • FRST Finance
  • Exchange
  • EDIT Nasdaq
  • FRST Nasdaq
  • Market Cap
  • EDIT 269.8M
  • FRST 261.7M
  • IPO Year
  • EDIT 2016
  • FRST 2006
  • Fundamental
  • Price
  • EDIT $2.40
  • FRST $11.21
  • Analyst Decision
  • EDIT Buy
  • FRST
  • Analyst Count
  • EDIT 10
  • FRST 0
  • Target Price
  • EDIT $4.13
  • FRST N/A
  • AVG Volume (30 Days)
  • EDIT 2.0M
  • FRST 66.3K
  • Earning Date
  • EDIT 11-10-2025
  • FRST 10-23-2025
  • Dividend Yield
  • EDIT N/A
  • FRST 3.57%
  • EPS Growth
  • EDIT N/A
  • FRST N/A
  • EPS
  • EDIT N/A
  • FRST 0.34
  • Revenue
  • EDIT $46,383,000.00
  • FRST $138,816,000.00
  • Revenue This Year
  • EDIT N/A
  • FRST $13.42
  • Revenue Next Year
  • EDIT N/A
  • FRST $35.45
  • P/E Ratio
  • EDIT N/A
  • FRST $32.97
  • Revenue Growth
  • EDIT N/A
  • FRST 33.08
  • 52 Week Low
  • EDIT $0.91
  • FRST $7.59
  • 52 Week High
  • EDIT $4.54
  • FRST $12.95
  • Technical
  • Relative Strength Index (RSI)
  • EDIT 34.46
  • FRST 59.46
  • Support Level
  • EDIT $2.30
  • FRST $10.62
  • Resistance Level
  • EDIT $2.55
  • FRST $11.05
  • Average True Range (ATR)
  • EDIT 0.20
  • FRST 0.29
  • MACD
  • EDIT -0.00
  • FRST 0.02
  • Stochastic Oscillator
  • EDIT 20.00
  • FRST 87.66

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

About FRST Primis Financial Corp.

Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, It focuses on making loans secured mainly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in several industries, as well as loans to individuals for a variety of purposes. Primis Bank offers a broad range of deposit products, including checking (NOW), savings, money market accounts, and certificates of deposit. Its operating segments are Primis Mortgage, Primis Bank, and Other.

Share on Social Networks: